已收盘 09-04 16:00:00 美东时间
+0.145
+2.38%
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从14美元升至14.5美元;HC Wainwright & Co.:维持Generate Biomedicines"买入"评级,目标价从25美元升至30美元
08-31 18:14
Lake Street analyst Ryan Meyers maintains Lifevantage (NASDAQ:LFVN) with a Hold and raises the price target from $5 to $6.
08-28 23:16
On Thursday, Lifevantage (NASDAQ:LFVN) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consult...
08-28 04:58
LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced due to the recent transition in the Chief Executive Officer role, the Company is not issuing formal guidance for fiscal 2027...
08-28 04:16
LifeVantage fiscal Q4 2026 revenue fell 23.1% to $42.4 million as orders weakened. Management withheld FY2027 guidance and outlined a digital reset.
08-27 22:00
LifeVantage Corporation (Nasdaq: LFVN), a leader in health and wellness products, announced that its Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, to be paid on September 15, 2026, to stockholders of record as of September 1, 2026. The company, a pioneer in nutrigenomics, offers a range of scientifically validated products designed to support optimal health processes at the cellular level. Founded ...
08-21 12:00
Security National Financial Corporation (SNFC) announced that Alissa Neufeld has joined as Chief Legal Officer, effective August 17, 2026. Neufeld brings extensive legal experience, including roles at LifeVantage Corporation and a clerkship on the U.S. Court of Appeals for the Ninth Circuit. She succeeds the retiring General Counsel after 20 years of service. SNFC’s Chairman, President, and CEO, Scott Quist, praised Neufeld’s leadership and abili...
08-17 14:30
LifeVantage Corporation announced that its Board of Directors granted inducement awards to new CEO Terrence Moorehead under the 2026 New Employee Long-Term Incentive Plan. The awards include 308,642 RSUs vesting annually over three years and 540,123 PSUs vesting based on revenue and Adjusted EBITDA margin targets. LifeVantage, a pioneer in nutrigenomics, offers products designed to support health through scientific validation. Founded in 2003, th...
08-11 21:00
LifeVantage Corporation appoints Terrence Moorehead as President and CEO, effective August 5, 2026. Moorehead, with over 25 years of experience in consumer wellness and brand transformation, previously led Nature’s Sunshine Products. The company, a pioneer in nutrigenomics, offers science-backed health products and operates through a network of independent consultants. Moorehead’s leadership is expected to drive growth and brand strengthening, al...
08-05 20:05
LifeVantage ( ($LFVN) ) just unveiled an update. On July 31, 2026, LifeVantage ...
08-04 04:44